Heart biological age

Biomarker1 paper1 finding

  • Human trial1

Interventions

1

Semaglutide

downin humans1

1 study
  1. Semaglutide decreases heart biological age in humans (approximately 2 to 4 years versus placebo).

    “Semaglutide reduced heart biological age by approximately 2 to 4 years versus placebo”

    Human trialheartup to 156 weeksn = 10,052

    Semaglutide reduces proteomic organ-specific biological age across randomized clinical trials · Research Square · 22 Sep 2026 · Preprint

Semaglutide →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01